84 related articles for article (PubMed ID: 2959758)
1. Relationship between regression of cardiovascular hypertrophy and rate of redevelopment of hypertension.
Korner PI; Jennings GL; Esler MD
J Clin Hypertens; 1987 Sep; 3(3):341-8. PubMed ID: 2959758
[No Abstract] [Full Text] [Related]
2. Effects of chronic chrysin treatment in spontaneously hypertensive rats.
Villar IC; Jiménez R; Galisteo M; Garcia-Saura MF; Zarzuelo A; Duarte J
Planta Med; 2002 Sep; 68(9):847-50. PubMed ID: 12357404
[TBL] [Abstract][Full Text] [Related]
3. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
Korner PI; Jennings GL; Esler MD; Broughton A
J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
[TBL] [Abstract][Full Text] [Related]
4. [Course of hypertension and the potentials for regression].
Shkhvatsabaia IK
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
[No Abstract] [Full Text] [Related]
5. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
Ruskoaho H
Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
Friberg P
Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic regression of cardiac hypertrophy in experimental hypertension.
Pfeffer MA; Pfeffer JM
J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S865-9. PubMed ID: 6084141
[TBL] [Abstract][Full Text] [Related]
8. Structural regression of the vasculature during antihypertensive treatment.
Jern S; Sivertsson R
J Clin Hypertens; 1987 Sep; 3(3):355-9. PubMed ID: 3668595
[No Abstract] [Full Text] [Related]
9. Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats.
Hubbard JW; Cox RH; Lawler JE; Blank ML; Snyder F
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):459-62. PubMed ID: 4059660
[TBL] [Abstract][Full Text] [Related]
10. Mechanical and other factors involved in vascular injury related to hypertension.
Mulvany MJ
Blood Press Suppl; 1994; 1():11-7. PubMed ID: 8205292
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of vascular smooth muscle in hypertension.
Mulvany MJ
J Hypertens Suppl; 1984 Dec; 2(3):S413-20. PubMed ID: 6400380
[No Abstract] [Full Text] [Related]
12. Normal left ventricular diastolic compliance after regression of hypertrophy.
Schraeger JA; Canby CA; Rongish BJ; Kawai M; Tomanek RJ
J Cardiovasc Pharmacol; 1994 Mar; 23(3):349-57. PubMed ID: 7515976
[TBL] [Abstract][Full Text] [Related]
13. Age-related increase in sensitivity for ischemic ATP breakdown in hypertrophic hearts of SHR normalized by enalapril.
Schoemaker RG; Leenen FH; Harmsen E
J Mol Cell Cardiol; 1994 May; 26(5):649-60. PubMed ID: 8072019
[TBL] [Abstract][Full Text] [Related]
14. Basis and clinical significance of regression of hypertensive hypertrophy.
Motz W; Zähringer J; Strauer BE
Basic Res Cardiol; 1986; 81 Suppl 1():171-8. PubMed ID: 2947563
[TBL] [Abstract][Full Text] [Related]
15. Early structural changes in hypertension: pathophysiology and clinical consequences.
Folkow B
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S1-6. PubMed ID: 7507535
[TBL] [Abstract][Full Text] [Related]
16. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension.
Korner PI; Bobik A; Jennings GL; Angus JA; Anderson WP
J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S25-32. PubMed ID: 1715480
[TBL] [Abstract][Full Text] [Related]
17. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide.
Idikio H; Fernandez PG; Triggle CR; Kim BK
Clin Invest Med; 1983; 6(1):43-8. PubMed ID: 6219850
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
19. Effects of varying salt diets and of ouabain on cardiovascular neuroeffector characteristics and on myogenic resistance vessel activity in SHR and WKY.
Nilsson H; Ely D; Friberg P; Karlström G; Folkow B
Klin Wochenschr; 1985; 63 Suppl 3():86-90. PubMed ID: 3999652
[No Abstract] [Full Text] [Related]
20. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
